The aim of this study is to investigate the effects of inhibiting Aurora-B on osteosarcoma (OS) cell malignant phenotype, phosphorylation of valosin-containing protein (VCP), and the activity of NF-κB signaling in vitro. The expressions of Aurora-B and p-VCP proteins were detected by immunohistochemistry in 24 OS tissues, and the relationship between Aurora-B and p-VCP was investigated. The results showed that there was a positive correlation between Aurora-B and p-VCP proteins. The expression of Aurora-B in human OS cell lines U2-OS and HOS cells was inhibited by specific short hairpin RNA (shRNA) lentivirus (AURKB-shRNA lentivirus, Lv-shAURKB) which targeted Aurora-B. The results showed that the phosphorylation of VCP, the activity of NF-κB signaling pathway and the malignant phenotype of OS cells were all suppressed by knockdown of Aurora-B. It indicated that the inhibition of Aurora-B alters OS cells malignant phenotype by downregulating phosphorylation of VCP and activating of the NF-κB signaling pathway in vitro.
The steroidal saponin RcE-4 (1β, 3β, 5β, 25S)-spirostan-1, 3-diol 1-[α-L-rhamnopyranosyl-(1→2)-βd-xylopyranoside], isolated from Reineckia carnea, exerts significant anti-cervical cancer activity by inducing apoptosis. The potential effect of RCE-4 on proliferation inhibition and autophagy induction has rarely been studied. Therefore, the focus of the present study was to investigate the effects of RCE-4 on proliferation, and to elucidate the detailed mechanisms involved in autophagy induction in cervical cancer cells. CaSki cells were treated with RCE-4 or/and autophagy inhibitors, and the effect of RCE-4 on cellular proliferation was assessed by MTT assay. The pro-autophagic properties of RCE-4 were subsequently confirmed using monomeric red fluorescent protein-green fluorescent protein-microtubule-associated proteins 1A/1B light chain 3B (LC3) adenoviruses and CYTO-ID autophagy assays, and by assessing the accumulation of lipid-modified LC3 (LC3II). The mechanisms of RCE-4-induced autophagy were investigated by western blot analysis. The results demonstrated that inhibiting autophagy significantly promoted RCE-4-induced cell death, indicating that autophagy served a protective role following RCE-4 treatment. In addition, RCE-4-induced autophagy was reflected by increased expression levels of the serine/threonine-protein kinase ULK1, phosphorylated (p)-ULK1, p-Beclin-1 and LC3II, the formation of autophagosomes and autolysosomes, and sequestosome 1 (p62) degradation. Subsequent analysis indicated that RCE-4 activated the AMP-activated protein kinase (AMPK) pathway by upregulating AMPK and p-AMPK, and also inhibited the PI3K and extracellular signal-regulated kinase (ERK) signaling pathways by downregulating p-PI3K, p-Akt, p-mTOR, Ras, c-Raf, p-c-Raf, dual specificity mitogen-activated protein kinase kinase (MEK)1/2, p-MEK1/2 and p-Erk1/2. Additionally, with increased treatment times RCE-4 may impair lysosomal cathepsin activity and inhibit autophagy flux by suppressing the expression of AMPK, p-AMPK, ULK1, p-ULK1 and p-Beclin-1, and upregulating that of p62. These results indicated that the dual RCE-4-induced inhibition of the PI3K and ERK pathways may result in a more significant anti-tumor effect and prevent chemoresistance, compared with the inhibition of either single pathway; furthermore, dual blockade of PI3K and ERK, and the AMPK pathway may be involved in the regulation of autophagy caused by RCE-4. Taken together, RCE-4 induced autophagy to protect cancer cells against apoptosis, but AMPK-mediated autophagy was inhibited in the later stages of RCE-4 treatment. In addition, autophagy inhibition improved the therapeutic effect of RCE-4. These data highlight RCE-4 as a potential candidate for cervical cancer treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.